A novel calcipotriol and betamethasone dipropionate (CAL/BDP) PAD-cream demonstrates greater improvements in daily activities and personal relationships than CAL/BDP gel/TS: A post-hoc analysis of DLQI outcomes from two phase 3 placebo-controlled randomized clinical trials in mild-to-moderate psoriasis

MeSH terms

• Betamethasone* / analogs & derivatives
• Betamethasone* / therapeutic use
• Calcitriol* / analogs & derivatives
• Clinical Trials, Phase III as Topic
• Dermatologic Agents* / therapeutic use
• Drug Combinations
• Humans
• Psoriasis* / drug therapy
• Randomized Controlled Trials as Topic
• Treatment Outcome